USA: A comprehensive meta-analysis published in BMC Cancer has highlighted a notable connection between cardiometabolic disorders and aggressive forms of prostate cancer . The study, conducted by Aurmin J. Amirmokri from the Epidemiology Program at Georgetown University, Washington, DC, and colleagues, emphasizes that diabetes, obesity, and hypertension are all associated with an elevated risk of developing high-grade or advanced prostate cancer. Drawing data from 25 cohort studies involving over 974,000 men, the researchers systematically evaluated the relationship between major cardiometabolic conditions—including diabetes, dyslipidemia, obesity, and hypertension—and the development of aggressive prostate cancer, defined as locally advanced (T3–T4, Grade Group 4–5), node-po

See Full Page